Cala stock price target

The latest closing stock price for Calithera Biosciences as of April 06, 2020 is tumor metabolism and tumor immunology targets for the treatment of cancer. Shop for cala foot file retail online at Target. Free shipping on orders of $35+ and save 5% every day with your Target RedCard. $13.19. Limited stock. Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing small molecule drugs that target novel 

Information about which ETFs are holding the stock CALA, Calithera Biosciences, Inc., from ETF Forgotten S&P 500 Giants: Analysts' Current Least Favorites engages in discovering and developing small molecule drugs that that target novel and critical metabolic pathway in tumor and cance-fighting immune cells. It   Mar 18, 2020 Based on the latest results, analysts are suggesting that the target price for CALA stock should be $3.79 per share in the course of the next 12  Tuesday, November 19, 2019 10:05 AM | InvestorsObserver Analysts. How Does the Market Feel About Calithera Biosciences Inc (CALA) Stock Tuesday? The latest closing stock price for Calithera Biosciences as of April 06, 2020 is tumor metabolism and tumor immunology targets for the treatment of cancer. Shop for cala foot file retail online at Target. Free shipping on orders of $35+ and save 5% every day with your Target RedCard. $13.19. Limited stock. Calithera Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering and developing small molecule drugs that target novel 

Get the latest Calithera Biosciences, Inc. (CALA) stock news and headlines to help you in your trading and investing decisions. 1y Target Est: N/A: Fair Value is the appropriate price for the

Shares of Calithera Biosciences Inc (NASDAQ:CALA) were down 31.7% during mid-day trading on Thursday after the company announced weaker than expected quarterly earnings. The company traded as low as $3.32 and last traded at $3.57, approximately 835,429 shares changed hands during trading. An increase of 80% from the average daily volume of 464,066 shares. The […] CALA - Calithera Biosci Com Stock Price - Barchart.com Calithera Biosci Com (CALA) Calithera Biosci Com (CALA) [[ item.lastPrice ]] It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Calithera Biosciences, Inc. (CALA): Price target? Calithera Biosciences, Inc. CALA Stock Message Board: Price target? Calithera Biosciences (NASDAQ:CALA) PT Lowered to $7.00 ...

Stifel likes bluebird bio in premarket analyst action ...

Calithera Biosciences - CALA - Stock Price & News | The ... Real time Calithera Biosciences (CALA) stock price quote, stock graph, news & analysis. Real time Calithera Biosciences (CALA) stock price quote, stock graph, news & analysis. CALA Stock Price and Chart — NASDAQ:CALA — TradingView After a recent selloff in mid June 2019, Stock price went from from $6.70 down to $3.44. Cala looks to have established a double bottom. New strong uptrend suggests it has potentially capitulated from the selloff making these levels very attractive for any investors who are sidelined and looking for a good technical/ fundamental trade in biotech. Calithera Biosciences Stock Quote: CALA Stock News, Quotes ... Nov 08, 2019 · CALA, Calithera Biosciences - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines

CALA:NASDAQ GS Stock Quote - Calithera Biosciences Inc ...

CALA Calithera Biosciences, Inc. Common Stock - NASDAQ.com Mar 26, 2020 · Calithera Biosciences, Inc. Common Stock (CALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Calithera Biosciences, Inc. Common Stock (CALA) Analyst ...

CA Technologies - CA - Stock Price & News | The Motley Fool

CALA Stock Price | Calithera Biosciences Inc. Stock Quote ...

Shares of Calithera Biosciences Inc (NASDAQ:CALA) were down 31.7% during mid-day trading on Thursday after the company announced weaker than expected quarterly earnings. The company traded as low as $3.32 and last traded at $3.57, approximately 835,429 shares changed hands during trading. An increase of 80% from the average daily volume of 464,066 shares. The […]